Schedule 13G ownership disclosure
CELLECTAR BIOSCIENCES INC
Security class unavailable · CUSIP: 15117F500
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,703,435
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-21-001032
- Form type
- SC 13G
- Filer
- Cellectar Biosciences, Inc.
- CIK
- CIK 1279704
- Filed
- Feb 17, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership